ATA902490A - Rekombinantes pockenvirus-wirtsselektionssystem - Google Patents
Rekombinantes pockenvirus-wirtsselektionssystemInfo
- Publication number
- ATA902490A ATA902490A AT0902490A AT902490A ATA902490A AT A902490 A ATA902490 A AT A902490A AT 0902490 A AT0902490 A AT 0902490A AT 902490 A AT902490 A AT 902490A AT A902490 A ATA902490 A AT A902490A
- Authority
- AT
- Austria
- Prior art keywords
- selection system
- host selection
- virus host
- small virus
- recombinant small
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/320,471 US5155020A (en) | 1989-03-08 | 1989-03-08 | Recombinant poxvirus host range selection system |
| US47817990A | 1990-02-14 | 1990-02-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA902490A true ATA902490A (de) | 1995-09-15 |
| AT400955B AT400955B (de) | 1996-05-28 |
Family
ID=26982509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0902490A AT400955B (de) | 1989-03-08 | 1990-03-02 | Rekombinantes pockenvirus-wirtsselektionssystem |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5453364A (de) |
| JP (1) | JP3044062B2 (de) |
| AT (1) | AT400955B (de) |
| AU (1) | AU625584B2 (de) |
| BE (1) | BE1004212A5 (de) |
| CA (1) | CA2011654C (de) |
| CH (1) | CH682669A5 (de) |
| DE (1) | DE4090351T1 (de) |
| DK (1) | DK157091A (de) |
| GB (1) | GB2245272B (de) |
| IE (1) | IE62441B1 (de) |
| IT (1) | IT1239987B (de) |
| LU (1) | LU88000A1 (de) |
| NL (1) | NL9020389A (de) |
| WO (1) | WO1990010693A1 (de) |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5505941A (en) * | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| US5364773A (en) * | 1991-03-07 | 1994-11-15 | Virogenetics Corporation | Genetically engineered vaccine strain |
| US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
| US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| DE10399032I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
| AU658836B2 (en) | 1990-09-25 | 1995-05-04 | Xenova Research Limited | Viral defective vaccine produced by transcomplementing cell line |
| US7374768B1 (en) | 1990-09-25 | 2008-05-20 | Xenova Research Limited | Viral vaccines |
| US5665362A (en) * | 1990-09-25 | 1997-09-09 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
| US5837261A (en) * | 1990-09-25 | 1998-11-17 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
| US5756102A (en) * | 1990-11-20 | 1998-05-26 | Virogenetics Corporation | Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
| US6309647B1 (en) | 1999-07-15 | 2001-10-30 | Aventis Pasteur | Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants |
| AU699903B2 (en) * | 1990-11-20 | 1998-12-17 | Virogenetics Corporation | Measles virus recombinant poxvirus vaccine |
| EP0575491B1 (de) * | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Gentechnologisch hergestellter stamm für impfstoffe |
| US5766598A (en) * | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products |
| DE69233080T2 (de) * | 1991-06-14 | 2004-04-15 | Connaught Technology Corp., Greenville | Rekombinanter hiv-spezifischer impfstoff aus poxviru |
| ATE181108T1 (de) | 1991-08-26 | 1999-06-15 | Immuno Ag | Direkt molekuläre klonierung eines modifizierten genoms eines chordopocken-virus |
| ES2243937T3 (es) * | 1994-04-29 | 2005-12-01 | Baxter Healthcare S.A. | Poxvirus recombinados en regiones esenciales con la ayuda de polinucleotidos extraños. |
| ES2264136T3 (es) | 1995-02-21 | 2006-12-16 | Cantab Pharmaceuticals Research Limited | Preparaciones virales, vectores, inmunogenos y sus vacunas. |
| JPH11514861A (ja) * | 1995-09-29 | 1999-12-21 | イミュネックス・コーポレーション | ケモカインインヒビター |
| AU2660397A (en) * | 1996-04-05 | 1997-10-29 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
| US6083715A (en) * | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| GB9711957D0 (en) | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| US20030138454A1 (en) * | 1997-06-09 | 2003-07-24 | Oxxon Pharmaccines, Ltd. | Vaccination method |
| WO1999043839A1 (en) | 1998-02-27 | 1999-09-02 | The Trustees Of The University Of Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
| AU779395B2 (en) | 1999-04-30 | 2005-01-20 | Institut De Recherche Cliniques De Montreal (Ircm) | Mutant human CD80 and compositions for and methods of making and using the same |
| US7851212B2 (en) * | 2000-05-10 | 2010-12-14 | Sanofi Pasteur Limited | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
| DK1301637T3 (da) * | 2000-07-14 | 2008-09-29 | Univ Pennsylvania | DNA-vacciner, der koder for HIV accessoriske proteiner |
| AU2002211490A1 (en) * | 2000-10-04 | 2002-04-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| WO2002100317A2 (en) | 2001-05-25 | 2002-12-19 | The Trustees Of The University Of Pennsylvania | Targeted particles and methods of using the same |
| GB0118532D0 (en) * | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| GB2396814B (en) | 2001-11-30 | 2006-07-19 | Isis Innovation | Fowlpox vector |
| WO2003072718A2 (en) * | 2002-02-22 | 2003-09-04 | Ivigene Corporation | In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization |
| WO2005035773A2 (en) * | 2003-10-08 | 2005-04-21 | Sanofi Pasteur, Inc. | Modified cea /b7 vector |
| ATE369895T1 (de) | 2002-04-09 | 2007-09-15 | Sanofi Pasteur Ltd | Modifizierte cea nucleinsäure und expressionsvektoren |
| ES2256747T3 (es) * | 2002-05-16 | 2006-07-16 | Bavarian Nordic A/S | Expresion de genes en el virus de la vacuna modificado, usando el promotor ati de la viruela de la vaca. |
| NZ570709A (en) | 2003-06-13 | 2010-04-30 | Univ Pennsylvania | Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same |
| AU2004249191B2 (en) | 2003-06-13 | 2011-01-06 | The Trustees Of The University Of Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
| US20050175627A1 (en) * | 2003-09-24 | 2005-08-11 | Oxxon Therapeutics Ltd. | HIV pharmaccines |
| WO2007050095A2 (en) | 2004-11-19 | 2007-05-03 | The Trustees Of The University Of Pennsylvania | Improved vaccines and methods for using the same |
| ATE533782T1 (de) * | 2006-01-13 | 2011-12-15 | Univ Pennsylvania | Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür |
| US9259463B2 (en) | 2006-01-16 | 2016-02-16 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chlamydia vaccine |
| KR102511874B1 (ko) | 2006-07-28 | 2023-03-20 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 백신 및 이의 사용 방법 |
| DK2212345T3 (en) * | 2007-11-19 | 2016-03-21 | Transgene Sa | Oncolytic poxvirus vectors |
| US9687515B2 (en) | 2007-11-19 | 2017-06-27 | Transgene S.A. | Poxviral oncolytic vectors |
| EP2274442B1 (de) * | 2008-04-04 | 2016-06-29 | The Trustees Of The University Of Pennsylvania | Konsensussequenzen von chikungunya-virusproteinen, dafür codierende nukleinsäuremoleküle und zusammensetzungen und verfahren zur verwendung davon |
| EP2265715B1 (de) | 2008-04-04 | 2016-12-28 | The Trustees Of The University Of Pennsylvania | Impfstoffe und immuntherapeutika unter verwendung von il-28 sowie zusammensetzungen und verfahren zur verwendung davon |
| US8921536B2 (en) | 2008-10-29 | 2014-12-30 | The Trustees Of The University Of Pennsylvania | HCV vaccines and methods for using the same |
| JP5753090B2 (ja) | 2008-10-29 | 2015-07-22 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 改良型hcvワクチンおよびその使用方法 |
| US9050287B2 (en) | 2009-01-23 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
| CA2653478A1 (en) * | 2009-01-23 | 2010-07-23 | Gregg Martin | Automated wash system for industrial vehicles |
| KR20120093163A (ko) | 2009-09-14 | 2012-08-22 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Il-15 수용체 알파 및/또는 이를 인코딩하는 핵산 분자를 포함하는 백신 및 면역 치료제, 및 이를 이용하는 방법 |
| BR112012010357B1 (pt) | 2009-11-02 | 2022-05-24 | Inovio Pharmaceuticals, Inc. | Proteínas de consenso de vírus de doença de febre aftosa (fmdv), sequências de codificação para as mesmas e vacinas feitas a partir das mesmas |
| US8298820B2 (en) | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
| WO2011097640A1 (en) | 2010-02-08 | 2011-08-11 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same |
| CN101935676A (zh) * | 2010-08-20 | 2011-01-05 | 中国海洋大学 | 一种诱导扇贝组织细胞体外转化的方法 |
| WO2012065164A2 (en) | 2010-11-12 | 2012-05-18 | The Trustees Of The University Of Pennsylvania | Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same |
| CA2826199A1 (en) | 2011-01-31 | 2012-08-09 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof |
| US9403879B2 (en) | 2011-02-11 | 2016-08-02 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same |
| US9238679B2 (en) | 2011-02-11 | 2016-01-19 | The Trustees Of The University Of Pennslyvania | Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same |
| KR102314421B1 (ko) | 2011-07-11 | 2021-10-19 | 이노비오 파마수티컬즈, 인크. | 교차-보호성 아레나바이러스 백신 및 이의 사용 방법 |
| KR102373828B1 (ko) | 2011-10-12 | 2022-03-14 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법 |
| KR20140084236A (ko) | 2011-10-24 | 2014-07-04 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 hcv 백신 및 이것을 사용하는 방법 |
| US9750795B2 (en) | 2011-12-12 | 2017-09-05 | The Trustees Of The University Of Pennsylvania | Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections |
| CN104245719B (zh) | 2011-12-12 | 2016-09-14 | 宾夕法尼亚大学托管会 | 包含改进的il-12基因构建体的组合物和疫苗、免疫治疗剂及其使用方法 |
| WO2013155205A1 (en) | 2012-04-10 | 2013-10-17 | The Trustees Of The University Of Pennsylvania | Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same |
| SG11201502221WA (en) * | 2012-09-21 | 2015-05-28 | Agency Science Tech & Res | Novel attenuated dengue virus strains for vaccine application |
| WO2014165291A1 (en) | 2013-03-12 | 2014-10-09 | The Trustees Of The University Of Pennsylvania | Improved vaccines for human papilloma virus and methods for using the same |
| MX428954B (es) | 2013-03-15 | 2025-11-13 | Univ Pennsylvania | Vacunación mejorada contra la hormona liberadora de la hormona de crecimiento (ghrh) humana. |
| WO2014145951A2 (en) | 2013-03-15 | 2014-09-18 | The Trustees Of The University Of Pennsylvania | Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
| RU2759681C1 (ru) | 2017-12-13 | 2021-11-16 | Иновио Фармасьютикалз, Инк. | Противораковые вакцины, нацеленные на boris, и способы их применения |
| CN111479583A (zh) | 2017-12-13 | 2020-07-31 | 艾诺奥医药品有限公司 | 靶向存活素的癌症疫苗和其用途 |
| CA3084135C (en) | 2017-12-13 | 2024-03-05 | Inovio Pharmaceuticals, Inc. | Cancer vaccines targeting muc16 and uses thereof |
| JP2021506255A (ja) | 2017-12-13 | 2021-02-22 | イノビオ ファーマシューティカルズ,インコーポレイティド | Prameを標的とするがんワクチンおよびその使用 |
| CN111479590A (zh) | 2017-12-13 | 2020-07-31 | 艾诺奥医药品有限公司 | 靶向间皮素的癌症疫苗及其使用 |
| CN112779293A (zh) * | 2021-01-27 | 2021-05-11 | 重庆市畜牧科学院 | 一种筛选LacZ基因标记山羊痘病毒的宿主细胞的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4703011A (en) * | 1985-11-12 | 1987-10-27 | Novagene, Inc. | Thymidine kinase deletion mutants of bovine herpesvirus-1 |
| FR2604183B1 (fr) * | 1986-09-23 | 1988-12-30 | Transgene Sa | Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho |
| CA1341245C (en) * | 1988-01-12 | 2001-06-05 | F. Hoffmann-La Roche Ag | Recombinant vaccinia virus mva |
| AU3776689A (en) * | 1988-06-10 | 1990-01-05 | Applied Biotechnology, Inc. | Method of selecting for recombinant pox viruses |
| US5310671A (en) * | 1988-06-24 | 1994-05-10 | British Technology Group Limited | Fowlpox virus non-essential regions |
| US5225336A (en) * | 1989-03-08 | 1993-07-06 | Health Research Incorporated | Recombinant poxvirus host range selection system |
| AU658836B2 (en) * | 1990-09-25 | 1995-05-04 | Xenova Research Limited | Viral defective vaccine produced by transcomplementing cell line |
-
1990
- 1990-03-02 DE DE4090351T patent/DE4090351T1/de not_active Withdrawn
- 1990-03-02 AU AU53320/90A patent/AU625584B2/en not_active Ceased
- 1990-03-02 JP JP2505067A patent/JP3044062B2/ja not_active Expired - Fee Related
- 1990-03-02 NL NL9020389A patent/NL9020389A/nl not_active Application Discontinuation
- 1990-03-02 AT AT0902490A patent/AT400955B/de not_active IP Right Cessation
- 1990-03-02 WO PCT/US1990/001268 patent/WO1990010693A1/en not_active Ceased
- 1990-03-02 CH CH3600/90A patent/CH682669A5/fr not_active IP Right Cessation
- 1990-03-07 CA CA002011654A patent/CA2011654C/en not_active Expired - Fee Related
- 1990-03-07 IE IE81490A patent/IE62441B1/en not_active IP Right Cessation
- 1990-03-08 BE BE9000259A patent/BE1004212A5/fr not_active IP Right Cessation
- 1990-03-08 IT IT19623A patent/IT1239987B/it active IP Right Grant
-
1991
- 1991-08-20 GB GB9117996A patent/GB2245272B/en not_active Expired - Fee Related
- 1991-09-04 LU LU88000A patent/LU88000A1/fr unknown
- 1991-09-06 DK DK157091A patent/DK157091A/da not_active IP Right Cessation
-
1993
- 1993-08-05 US US08/102,702 patent/US5453364A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE4090351T1 (de) | 1997-07-24 |
| IE900814L (en) | 1990-09-08 |
| CA2011654A1 (en) | 1990-09-08 |
| IT1239987B (it) | 1993-11-27 |
| NL9020389A (nl) | 1991-12-02 |
| GB9117996D0 (en) | 1991-10-09 |
| IE62441B1 (en) | 1995-02-08 |
| AU625584B2 (en) | 1992-07-16 |
| IT9019623A0 (it) | 1990-03-08 |
| GB2245272B (en) | 1993-03-17 |
| JP3044062B2 (ja) | 2000-05-22 |
| WO1990010693A1 (en) | 1990-09-20 |
| IT9019623A1 (it) | 1991-09-08 |
| AU5332090A (en) | 1990-10-09 |
| GB2245272A (en) | 1992-01-02 |
| US5453364A (en) | 1995-09-26 |
| AT400955B (de) | 1996-05-28 |
| CA2011654C (en) | 1995-12-19 |
| LU88000A1 (fr) | 1992-03-11 |
| BE1004212A5 (fr) | 1992-10-13 |
| JPH04503904A (ja) | 1992-07-16 |
| CH682669A5 (fr) | 1993-10-29 |
| DK157091A (da) | 1991-09-26 |
| DK157091D0 (da) | 1991-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4090351T1 (de) | Rekombinantes Pockenvirus-Wirtsselektionssystem | |
| ATA902590A (de) | Rekombinantes pockenvirus | |
| DK603888D0 (da) | Rekombinant virus | |
| FR2621487B1 (fr) | Virus avipox recombinant | |
| ATA257190A (de) | Virales polypeptid | |
| ZA901676B (en) | Recombinant poxvirus host range selection system | |
| ATE120489T1 (de) | Rekombinante coccidiosis-vakzine. | |
| DE69030908D1 (de) | Akustisch-digitales System | |
| NO914402D0 (no) | Roer-haandteringssystem | |
| FR2620459B1 (fr) | Virus recombinant de la vaccine | |
| DK0517292T3 (da) | Rekombinant Avipox-virus | |
| DE69030931D1 (de) | Mehrfachsequenzprozessorsystem | |
| DE69101683D1 (de) | Rekombinantes Mareks-Krankheitsvirus. | |
| DE69031206D1 (de) | Rechnersystem | |
| DK111489D0 (da) | Peptider | |
| DE69031904D1 (de) | Dateiensystem | |
| DE69032145D1 (de) | Schnittstellensteuerungssystem | |
| FI905741A7 (fi) | Peptidit | |
| FI900011A0 (fi) | Kolmoisvetoakselijärjestelmä | |
| DE69024912D1 (de) | Rechnersystem | |
| DK219187A (da) | Rekombinant-virus | |
| DE59005377D1 (de) | Rechnersystem. | |
| DK381789D0 (da) | Peptider | |
| DE3890874T1 (de) | Rekombinante avipoxviren | |
| SE8901165D0 (sv) | Styrsystem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |